InsidersTradesSigma
Browse the complete record of transactions filed by Apelian David, Director. Officer active across 1 company, notably Eiger BioPharmaceuticals, Inc.. Cumulatively, 1 disclosures have been logged. History available since 11 March 2022. The latest transaction was filed on 11 March 2022 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
1 of 1 declaration
David Apelian serves as a Board Member at Eiger BioPharmaceuticals, Inc. In this role, he contributes to the strategic direction of the company, which focuses on developing treatments for rare diseases. His experience in the biopharmaceutical sector allows him to provide valuable expertise to the board.